Merck to take legal action against unauthorised distributors of its COVID treatment in China Reuters Jan 12, 2023 Merck added that Sinopharm is the only legally authorised distributor of Merck's COVID-19 anti-viral molnupiravir in China
UK government to purchase additional 1.75 million courses of Molnupiravir EP News Bureau Dec 23, 2021 With this additional procurement agreement, which follows a previously announced agreement for 480,000 courses of treatment, the…
